DE602004032262D1 - PROCESS FOR THE CYLOGRANULATION AND STORAGE OF ALLERGENS - Google Patents

PROCESS FOR THE CYLOGRANULATION AND STORAGE OF ALLERGENS

Info

Publication number
DE602004032262D1
DE602004032262D1 DE602004032262T DE602004032262T DE602004032262D1 DE 602004032262 D1 DE602004032262 D1 DE 602004032262D1 DE 602004032262 T DE602004032262 T DE 602004032262T DE 602004032262 T DE602004032262 T DE 602004032262T DE 602004032262 D1 DE602004032262 D1 DE 602004032262D1
Authority
DE
Germany
Prior art keywords
low temperature
temperature particles
relates
particles
storing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004032262T
Other languages
German (de)
Inventor
Martin Richter-Friis
Signe Kolmos Andersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
ALK Abello AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALK Abello AS filed Critical ALK Abello AS
Priority claimed from PCT/DK2004/000878 external-priority patent/WO2005058474A1/en
Publication of DE602004032262D1 publication Critical patent/DE602004032262D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • F26B5/065—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing the product to be freeze-dried being sprayed, dispersed or pulverised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a volume production method for preparing active medicament components such as allergenic products. The present invention also relates to a container containing low temperature particles of liquid combinations of the allergenic products, and further relates to low temperature particles of the allergenic products. The method for preparing and storing low temperature particles for an active medicament is characterized by using a container containing low temperature medium (such as liquid nitrogen), and storing the low temperature particles in a same container. The low temperature particles do not undergo freeze-drying before storage and processing.
DE602004032262T 2003-12-19 2004-12-17 PROCESS FOR THE CYLOGRANULATION AND STORAGE OF ALLERGENS Active DE602004032262D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301896 2003-12-19
US53167903P 2003-12-23 2003-12-23
PCT/DK2004/000878 WO2005058474A1 (en) 2003-12-19 2004-12-17 Cryogranulation and storage method for active pharmaceutical agents

Publications (1)

Publication Number Publication Date
DE602004032262D1 true DE602004032262D1 (en) 2011-05-26

Family

ID=34973435

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004032262T Active DE602004032262D1 (en) 2003-12-19 2004-12-17 PROCESS FOR THE CYLOGRANULATION AND STORAGE OF ALLERGENS

Country Status (6)

Country Link
JP (1) JP4755992B2 (en)
CN (2) CN1894026B (en)
AT (1) ATE505263T1 (en)
DE (1) DE602004032262D1 (en)
DK (1) DK1697033T3 (en)
ES (1) ES2363342T3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127173B (en) * 2013-03-06 2015-01-21 苏州市红冠庄国药饮片有限公司 Atomizing multi-layer covering and crystallizing process for producing beer blood crystal
CN114160040B (en) * 2021-12-09 2022-07-12 广州风行乳业股份有限公司 Liquid nitrogen cryogenic granulation equipment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5242846B2 (en) * 1974-04-03 1977-10-27
WO2000006179A1 (en) * 1998-07-31 2000-02-10 Eli Lilly And Company Cryogranulation of activated protein c
CA2397404C (en) * 2000-01-14 2008-12-02 Brown University Research Foundation Micronized freeze-dried particles
MXPA03004174A (en) * 2000-11-16 2004-12-02 Alk Abello As Novel mutant allergens.
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof

Also Published As

Publication number Publication date
DK1697033T3 (en) 2011-06-27
JP4755992B2 (en) 2011-08-24
JP2007514490A (en) 2007-06-07
ES2363342T3 (en) 2011-08-01
ATE505263T1 (en) 2011-04-15
CN1894026A (en) 2007-01-10
CN1894026B (en) 2012-01-25
CN102657863A (en) 2012-09-12

Similar Documents

Publication Publication Date Title
MX343419B (en) Drying process.
DE60024612D1 (en) METHOD FOR PRODUCING CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS
ATE315050T2 (en) METHOD FOR PRODUCING MULTIPLE CROSS-LINKED HYALURONIC ACID DERIVATIVES
EP0054799A3 (en) A dried, sterilized, gamma-globulin-fixed column and a process for preparing the same
ATE331744T1 (en) METHOD AND COMPOSITION FOR RAPID MASS PRODUCTION OF HOLOGRAPHIC RECORDING ITEMS
WO2001068811A3 (en) Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material
GEP20074234B (en) Cyclic protein tyrosine kinase inhibitors
DE502005007475D1 (en) PROCESS FOR THE PRODUCTION OF MENTHOL
WO2006062808A3 (en) Stabilized products, process and devices for preparing same
DE602004024925D1 (en) PROCESS FOR PREPARING A LOOK WITH A SCLEROSING AGENT
HUP9901309A2 (en) A highly purified biogenic silica product
DE602004032262D1 (en) PROCESS FOR THE CYLOGRANULATION AND STORAGE OF ALLERGENS
ATE481165T1 (en) METHOD FOR PRODUCING PARTICLES FROM AN EMULSION IN SUPERCRITICAL OR LIQUID CO2
DE3685973D1 (en) METHOD FOR PRODUCING A PRODUCT OF GELLED CELLULOSE TRIACETATE AND THE PRODUCT PRODUCED IN THIS PROCESS.
ATE384001T1 (en) METHOD FOR PRODUCING MOSAGE INHALER FORMULATIONS
BRPI0417264A (en) processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranes of an allergen product, and a cryogran of an allergen product
DE60118739D1 (en) PROCESS FOR INSULATING A PROTEIN
HK1111136A1 (en) Demonstration package
DE60009713D1 (en) Method for inactivating microorganisms using high pressure processes
ATE266719T1 (en) METHOD AND COMPOSITION FOR PRODUCING DESICION-TOLERANT SPORES OF PAECITOMYCES FUMOSOROSEUS
GB0504501D0 (en) Liquids containing suspended glass particles
DE60004850D1 (en) METHOD FOR PRODUCING (R) AND (S) -AMINOCARNITINE AND THEIR DERIVATIVES FROM D- AND L-ASPARGINIC ACID
DE502004005702D1 (en) 4-cyclohexyl-2-butanol als riechstoff
ATE281241T1 (en) METHOD FOR DRUG ACTIVATION IN A VIBRATION MILL
ATE282616T1 (en) METHOD FOR PRODUCING ANHYDROUS MIRTAZAPINE CRYSTALS.